Download presentation
Presentation is loading. Please wait.
Published byShanon Simmons Modified over 9 years ago
1
BioPSE NCRR SCIRun2 -THE PROJECT -OBJECTIVES -DEVELOPMENTS -TODAY -THE FUTURE
2
BioPSE NCRR SCIRun2: THE PROJECT OBJECTIVE To develop software component technology for high-performance, parallel, scientific computing.
3
BioPSE NCRR SCIRun2: THE PROJECT CCA FORUM A project committed to defining a standard component architecture for high performance computing.
4
BioPSE NCRR SCIRun2: THE PROJECT CCA PARTICIPANTS Argonne National Laboratory Indiana University The Advanced Computing Laboratory at Los Alamos National Laboratory Lawrence Livermore National Laboratory Oak Ridge National Laboratory Sandia National Laboratory University of Utah
5
BioPSE NCRR SCIRun2: THE PROJECT CCA SOFTWARE Ccaffeine – a CCA component framework for parallel computing CumulvsMxN – provides basic “MxN” Parallel Dad Redistribution functionality Tao – large scale optimization problems PAWs – Parallel Application Work Space SCIRun – rapid prototyping, extensible PSE
6
BioPSE NCRR SCIRun2: OBJECTIVES -Builder Service -GUI Component -MxN Research -Creation of parallel, multi- threaded GUI components -Use GUI components for visualization and numerical computation
7
BioPSE NCRR SCIRun2: DEVELOPMENTS -Builder Service -Qt construction -SCIRun integration -CCA | SIDL components -Parallel
8
BioPSE NCRR SCIRun2: DEVELOPMENTS BUILDER SERVICE
9
BioPSE NCRR SCIRun2: DEVELOPMENTS Qt FUNCTIONALITY
10
BioPSE NCRR SCIRun2: DEVELOPMENTS MESH EXAMPLE
11
BioPSE NCRR SCIRun2: DEVELOPMENTS MESH EXAMPLE
12
BioPSE NCRR SCIRun2: DEVELOPMENTS CCA COMPONENTS
13
BioPSE NCRR SCIRun2: TODAY -XUL: Create customized builders -PIDL: Merging PIDL with BABEL -MxN PROTOTYPE -BABEL EXAMPLES -FRAMEWORK IMPROVEMENTS
14
BioPSE NCRR SCIRun2: THE FUTURE -SCIRun | CCA component interoperability -Merge PIDL and BABEL -XUL: Implementation of dynamic builders -MxN: Integration of prototypes -SCIRun2 tutorials
15
BioPSE NCRR SCIRun2
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.